Skip to content

Clinical trials

Muscle Weakness trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscle Weakness Phase: Not applicable Clear all

276 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20052
20061
20071
20084
20091
20102
20115
20123
20138
201415
201513
201612
201718
201830
201920
202019
202125
202228
202322
202425
202512
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed180
Unknown status46
Recruiting18
Terminated10
Active, not recruiting8
Not yet recruiting6
Withdrawn4
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University8
Hacettepe University6
Cairo University4
Charite University, Berlin, Germany4
University of Chile4
University of Erlangen-Nürnberg Medical School4
Centre Hospitalier Universitaire de Saint Etienne3
National Yang Ming Chiao Tung University3
Universitat Internacional de Catalunya3
University of Central Florida3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscle Weakness276
Muscular Atrophy25
Critical Illness18
Sarcopenia13
Fatigue12
Stroke11
Frailty9
Pulmonary Disease, Chronic Obstructive8
COVID-197
Respiratory Insufficiency7

Trials

Showing 1 to 25 of 276. Each trial links to its page on Pharma Observatory.

176 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.